You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Chemistry
- Asymmetric Synthesis
- High-Speed Synthesis and purification
- Metabolite Synthesis (Phase I and II)
- Molecular Probes (Fluorophores and Biotinylated Targets)
- Structure Identification and Characterization
- Stable Isotopically Labeled Compounds (2H, 13C, 15N, 34S)
- Specific Chemistry Expertise
- Natural Product Synthesis
- Instrumentation and Computing
Stable Isotopically Labeled Compounds (2H, 13C, 15N, 34S)
Using various analytical techniques, such as 1D and 2D NMR, HPLC, and LCMS, our experienced chemists can elucidate compound structure and provide certificate of analysis and detail report for your project.
Learn more about